Home > News > featured news > ClareMedica Health Partners, a Leading Provider of Value-Based Primary Care, Receives Investment from Revelstoke Capital Partners

FUTURE OF HEALTHCARE

ClareMedica Health Partners, a Leading Provider of Value-Based Primary Care, Receives Investment from Revelstoke Capital Partners

Revelstoke | February 25, 2022

Revelstoke Capital Partners ("Revelstoke"), a Denver-based private equity firm focused on investing in healthcare services companies, today announced it has made a significant growth investment in ClareMedica Health Partners, LLC ("ClareMedica" or the "Company"), a leader in value-based primary care serving Medicare Advantage members in Florida. This partnership will accelerate ClareMedica's growth and aid the Company in expanding its BetterCare℠ model into new markets.

ClareMedica will continue to be led by CEO Roberto Palenzuela and the current management team, who will retain significant ownership in the business. BPOC, a Chicago-based healthcare investor, which has been an investor in ClareMedica since 2019, will also retain equity ownership.

"We have always believed in a value-based care model that places a priority on high-quality coordinated care designed to improve health outcomes," said Mr. Palenzuela, who reinvested alongside Revelstoke. "We are delighted to partner with Revelstoke, which has a proven track-record of building prominent healthcare services businesses with this patient centric philosophy. We are excited to use this investment to partner with other physician-led practices, expanding our BetterCare℠ model into new markets throughout Florida and into neighboring states."

Russell Cassella, Managing Partner at Revelstoke, said, "Our investment in ClareMedica reflects Revelstoke's avid support of the industry's transition from fee-for-service to value-based healthcare, resulting in a greater emphasis on improving patient outcomes. ClareMedica's commitment to providing high-quality care has made it a partner of choice for physicians and payors throughout Florida. With our experience in physician practice management and value-based care, we look forward to helping management build a broader regional platform that will increase access to high-quality care."

"We look forward to our continued partnership with Roberto and his team because of their patient-centered approach and focus on improving patient outcomes. As value-based care continues to expand, we see significant long-term growth potential as ClareMedica enters new markets and expands access to high-quality care."

Peter Magas, Partner at BPOC

"After a multi-year outbound search in the value-based primary care sector, we are very pleased to partner with ClareMedica's management team and providers who are dedicated to transforming healthcare," said Cy Barton-Dobenin, Principal at Revelstoke. "Throughout our targeted search process, we have built significant industry knowledge and strategic relationships that we are excited to integrate into ClareMedica's growth plans."

SVB Leerink acted as financial advisor and McGuireWoods LLP acted as legal counsel to Revelstoke.��Houlihan Lokey acted as financial advisor and Kirkland & Ellis LLP and McDermott Will & Emery LLP acted as legal counsel to ClareMedica and BPOC. Terms of the transaction were not disclosed.

About Revelstoke

Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies in the healthcare services and healthcare technology sectors. Revelstoke partners with entrepreneurs and management teams to execute on a disciplined organic and acquisition growth strategy as it strives to build exceptional companies. Revelstoke is based in Denver, Colorado and has approximately $4.3 billion of assets under management. Since the firm's inception in 2013, Revelstoke has completed 142 acquisitions, which includes 25 platform companies and 117 add-on acquisitions.

About ClareMedica Health Partners

ClareMedica is a growing health care company that provides and coordinates comprehensive health care services for Medicare Advantage members and other customers through a network of employed and affiliated physicians. We deliver accountable, value-based care for all health care stakeholders by employing a patient-centric care model that provides better care for our patients and a changing health care industry.

About BPOC

Founded in 1996, BPOC is a Chicago-based private equity firm that invests exclusively in healthcare companies and is one of the nation's most experienced investors in the industry having raised five funds with total capital commitments of nearly $1.8 billion. BPOC has invested in numerous provider, manufacturing, outsourcing, distribution and information technology companies through growth equity, management buyouts and leveraged recapitalizations.

Spotlight

Introducing the Responsible AI dashboard accelerator kit for healthcare

Azure Machine Learning includes a responsible AI dashboard that helps you check models for fairness, explainability, and error analysis before they are deployed in healthcare settings.

More featured news

Spotlight

Introducing the Responsible AI dashboard accelerator kit for healthcare

Azure Machine Learning includes a responsible AI dashboard that helps you check models for fairness, explainability, and error analysis before they are deployed in healthcare settings.

Related News

HEALTH TECHNOLOGY, HEALTHCARE ANALYTICS

Nova Scotia Selects OceanMD for Electronic Surgical Consult Referrals to Help Reduce Wait Times

Prnewswire | April 05, 2023

WELL Health Technologies Corp. a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that pursuant to an announcement made on March 29, 2023, the Province of Nova Scotia is introducing a new electronic tool, Ocean eReferrals, to manage surgical referrals and make the process more efficient for physicians and patients. This new system will help patients receive better information on the status of their referral and will lead to shorter wait times in the long run. The goal is to improve the process of sending and receiving surgical referrals for both primary care providers and surgeons, to support improved access and provide better information to support planning and care. Nova Scotia's Health and Wellness Minister, Michelle Thompson, stated "Waiting for care is hard for patients and their families. It's also frustrating for healthcare professionals when they don't have the information to answer their patients' questions. Nova Scotians deserve short wait times that will keep them out of pain and allow them to move on with their lives." Jeff Kavanagh, CEO of OceanMD, a subsidiary of WELL, commented, "We are thrilled to work with the Province of Nova Scotia to address the growing need for an electronic referral system across the entire province. We applaud the work of the Department of Health and Wellness in leading this initiative to create an efficient process to reduce wait times and provide critical information to the people of Nova Scotia." Through the new system, primary care providers will send their requests for surgical consultations via e-referral, rather than faxing, emailing, or mailing requests directly to a surgeon. This method of referral will enable better tracking, review, and management of referrals, and will eventually include consult wait time information to help ensure patients have faster access to care. Patients who provide their email address and referring providers will receive automatic notifications when their referral is received, forwarded to a surgeon, and when a consult is booked or changed. This feature will provide patients with greater visibility into the referral process and enable them to stay informed throughout their journey. Ocean eReferrals was made available to primary care providers and surgeons at Nova Scotia Health and IWK Health as of Friday, March 31, 2023. About WELL Health Technologies WELL is a practitioner-focused digital healthcare company. WELL's overarching mission is to positively impact health outcomes by leveraging technology to empower healthcare practitioners and their patients globally. WELL exists to enable healthcare practitioners with best-in-class technology and services. WELL has built the most comprehensive end-to-end healthcare system across Canada including the nation's largest network of clinics supporting primary care, specialized care, and diagnostics services. In the United States, WELL provides omni-channel healthcare services and solutions targeting specialized markets such as the gastrointestinal market, women's health, primary care, and mental disorders. In addition to providing patient services, WELL develops, integrates, and sells its own suite of technology software and solutions to medical clinics and healthcare practitioners. WELL's practitioner enablement platform includes: Electronic Medical Records ("EMR"), telehealth platforms, practice management, billing, Revenue Cycle Management digital health apps and data protection solutions. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF".

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

HEALTH TECHNOLOGY, MEDICAL DEVICES

Streamline Unveils New Brand for Company, SmartCare™ Behavioral Health EHR

Businesswire | May 02, 2023

Streamline Healthcare Solutions, a leading provider of Electronic Health Record (EHR) solutions to the Behavioral Health market, today unveiled its new brand for the company and its SmartCare™ EHR platform as part of its 20th Anniversary celebrations. “We can’t think of a better way to celebrate 20 years than by unveiling a new brand, one that captures the essence of all we’ve learned over two decades in behavioral health and how that informs our mission of empowering behavioral health professionals to advance the lives of those in need,” said Streamline Co-Founder and CEO Javed Husain. Streamline was founded in 2003 by Javed Husain and David Ryland. The company’s SmartCare™ EHR platform sets a new standard for Behavioral Health EHRs. Its dependability and stability provide organizations with the control they need to succeed in today’s complex environment, while its flexibility enables them to transform the way they provide care to meet the exciting promise of tomorrow. “People choose to work in behavioral health out of a deep desire to help others weather life’s storms. We partner with our customers to provide innovative technology solutions that help them achieve this goal,” Husain said. About Streamline and SmartCare™ Since 2003, Streamline has focused exclusively on the Behavioral Health market. Understanding that organizations in this market need more than just another Electronic Health Record (EHR) vendor, the company is a trusted partner in building innovative technology solutions that empower people to improve the quality of life for those in need. SmartCare™ is a true enterprise solution built on a stable, single platform with robust analytics so organizations and users alike have the control they need to operate more efficiently and provide care more effectively. The platform’s individualized, intuitive and intelligent design provides users with the flexibility not just to adapt to today’s challenges but to transform the way they provide care in the future.